Can Improved Prescription Medication Labeling Influence Adherence to Chronic Medications? An Evaluation of the Target Pharmacy Label
- 347 Downloads
Prescription medication labels contain valuable health information, and better labels may enhance patient adherence to chronic medications. A new prescription medication labeling system was implemented by Target pharmacies in May 2005 and aimed to improve readability and understanding.
We evaluated whether the new Target label influenced patient medication adherence.
DESIGN AND PATIENTS
Using claims from two large health plans, we identified patients with one of nine chronic diseases who filled prescriptions at Target pharmacies and a matched sample who filled prescriptions at other community pharmacies.
We stratified our cohort into new and prevalent medication users and evaluated the impact of the Target label on medication adherence. We used linear regression and segmented linear regression to evaluate the new-user and prevalent-user analyses, respectively.
Our sample included 23,745 Target users and 162,368 matched non-Target pharmacy users. We found no significant change in adherence between new users of medications at Target or other community pharmacies (p = 0.644) after implementing the new label. In prevalent users, we found a 0.0069 percent reduction in level of adherence (95% CI −0.0138-0.0; p < 0.001) and a 0.0007 percent increase in the slope in Target users (the monthly rate of change of adherence) after implementation of the new label (95% CI 0.0001–0.0013; p = 0.001).
We found no changes in adherence of chronic medication in new users, and small and likely clinically unimportant changes in prevalent users after implementation of the new label. While adherence may not be improved with better labeling, evaluation of the effect of labeling on safety and adverse effects is needed.
KEY WORDSlabel prescription medication adherence
This work was supported by a Pioneer Award from the Robert Wood Johnson Foundation.
Dr. Shrank is supported by a career development award from the National Heart, Lung and Blood Institute (K23HL090505-01). Dr. Brookhart is supported by a career development award from the National Institute of Aging (AG-027400).
Drs. Shrank, Avorn, Choudhry, Schneeweiss, and Brookhart receive research funding from CVS Caremark for studies on medication adherence.
We would like to thank Joy Lee for her administrative and technical help with the project.
Conflict of Interest
- 1.World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva, Switzerland: WHO; 2003. Available at: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf Accessed 1/26/09.
- 5.National Council on Patient Information and Education. Enhancing prescription medication adherence: a national action plan. Aug. 2007. Available at: http://www.talkaboutrx.org/documents/enhancing_prescription_medicine_adherence.pdf. Accessed 6/2/2008.
- 9.Svarstad BL, Bultman DC, Mount JK. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness. J Am Pharm Assoc (Wash DC). 2004;44(1):22–9.Google Scholar
- 15.Haynes RB, McDonald H, Garg AX. Interventions for helping patients to follow prescriptions for medications. Oxford, England: Cochrane library, Update software; 2002; issue 2.Google Scholar
- 17.Bull, G. USA Today. April 28, 2005. Available at: http://www.usatoday.com/money/industries/health/drugs/2005-04-28-target-pill_x.htm?csp = 34. Accessed 01/26/09
- 18.Samet JH, Libman H, Steger KA, Dhawan RK, Chen J, Shevitz AH, Dewees-Dunk R, Levenson S, Kufe D, Craven DE. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am J Med. 1992;92(5):495–502.PubMedCrossRefGoogle Scholar
- 22.Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;(42):121–30.Google Scholar